We are live on
!
Find out more
AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
46 hedge funds and large institutions have $4.55M invested in Accelerate Diagnostics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
900% more call options, than puts
Call options by funds: $20K | Put options by funds: $2K
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
7% more funds holding
Funds holding: 43 → 46 (+3)
54% less capital invested
Capital invested by funds: $9.79M → $4.55M (-$5.24M)
Holders
46
Holders Change
+3
Holders Change %
+6.98%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
10
Reduced
8
Closed
6
Calls
$20K
Puts
$2K
Net Calls
+$18K
Net Calls Change
+$20K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$2.92M |
| 2 |
GAM
Griffin Asset Management
New York
|
+$212K |
| 3 |
CS
Cannell & Spears
New York
|
+$181K |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
+$158K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$127K |
